1Life Healthcare
ONEM
ONEM was delisted on the 21st of February, 2023.
230 hedge funds and large institutions have $3.27B invested in 1Life Healthcare in 2022 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 86 increasing their positions, 57 reducing their positions, and 26 closing their positions.
51% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 57
50% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 26
38% more funds holding in top 10
Funds holding in top 10: 13 → 18 (+5)
9% more capital invested
Capital invested by funds: $3B → $3.27B (+$272M)
4% more funds holding
Funds holding: 222 → 230 (+8)
75% less call options, than puts
Call options by funds: $14.5M | Put options by funds: $57.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
HBK Investments
Dallas,
Texas
|
+$99.8M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$89.9M |
| 3 |
TAL
TIG Advisors LLC
New York
|
+$62.6M |
| 4 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$37.2M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$30.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SHG
Sheares Healthcare Group
Singapore
|
-$139M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.5M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$29.7M |
| 4 |
Bank of New York Mellon
New York
|
-$28.4M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$14.3M |
ONEM Hedge Fund Activity: Q4 2022 in Review
230 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in 1Life Healthcare (ONEM) for Q4 2022, worth a combined $3.27B — up 9.1% from $3B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ONEM positions and 26 closed out — a net gain of 13 holders — while 86 added to existing stakes and 57 trimmed.
The largest buyer was HBK Investments, adding an estimated $99.8M. The largest seller was Sheares Healthcare Group, cutting an estimated $139M.
- 230 institutional investors held 1Life Healthcare (ONEM) as of Q4 2022, up from 222 in Q3 2022.
- Funds reported $3.27B of 1Life Healthcare stock for Q4 2022, up 9.1% quarter-over-quarter.
- 39 funds opened new 1Life Healthcare positions in Q4 2022 and 26 closed out, a net change of +13 holders.
- The largest 1Life Healthcare buyer in Q4 2022 was HBK Investments, an estimated $99.8M added.
- The largest 1Life Healthcare seller in Q4 2022 was Sheares Healthcare Group, an estimated $139M sold.
Based on aggregated 13F filings for Q4 2022.